Logo image of AXAS

Abraxas Petro Corp (AXAS) Stock Fundamental Analysis

NASDAQ:AXAS - Nasdaq -

1.84  -0.1 (-5.15%)

After market: 1.86 +0.02 (+1.09%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to AXAS. AXAS was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. AXAS may be in some trouble as it scores bad on both profitability and health. AXAS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AXAS had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -180.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -374.64%
PM (TTM) -567.57%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for AXAS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

AXAS has an Altman-Z score of -13.23. This is a bad value and indicates that AXAS is not financially healthy and even has some risk of bankruptcy.
AXAS has a Debt/Equity ratio of -0.03. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.03
Debt/FCF N/A
Altman-Z -13.23
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.08 indicates that AXAS may have some problems paying its short term obligations.
AXAS has a Quick Ratio of 0.08. This is a bad value and indicates that AXAS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08

More info and screens

0

3. Growth

3.1 Past

The earnings per share for AXAS have decreased strongly by -149000.00% in the last year.
AXAS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -36.58% yearly.
Looking at the last year, AXAS shows a very negative growth in Revenue. The Revenue has decreased by -60.14% in the last year.
The Revenue has been decreasing by -8.48% on average over the past years.
EPS 1Y (TTM)-149000%
EPS 3Y-42.26%
EPS 5Y-36.58%
EPS Q2Q%-158.96%
Revenue 1Y (TTM)-60.14%
Revenue growth 3Y-20.68%
Revenue growth 5Y-8.48%
Sales Q2Q%6%

3.2 Future

AXAS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -34.73% yearly.
The Revenue is expected to decrease by -23.81% on average over the next years. This is quite bad
EPS Next Y0%
EPS Next 2Y-53.96%
EPS Next 3Y-43.38%
EPS Next 5Y-34.73%
Revenue Next Year29.96%
Revenue Next 2Y-45.16%
Revenue Next 3Y-31.89%
Revenue Next 5Y-23.81%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AXAS Yearly Revenue VS EstimatesAXAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AXAS Yearly EPS VS EstimatesAXAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AXAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AXAS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXAS Price Earnings VS Forward Price EarningsAXAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.55
AXAS Per share dataAXAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

AXAS's earnings are expected to decrease with -43.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-53.96%
EPS Next 3Y-43.38%

More info and screens

0

5. Dividend

5.1 Amount

AXAS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Abraxas Petro Corp

NASDAQ:AXAS (8/3/2021, 8:00:00 PM)

After market: 1.86 +0.02 (+1.09%)

1.84

-0.1 (-5.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)05-05 2022-05-05/dmh
Inst Owners0%
Inst Owner Change0%
Ins Owners1158.43%
Ins Owner Change0%
Market Cap15.50M
Analysts20
Price Target3.06 (66.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -1.55
EPS(TTM)-29.82
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.22
BVpS-11.44
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -180.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -374.64%
PM (TTM) -567.57%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity -0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -13.23
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-149000%
EPS 3Y-42.26%
EPS 5Y-36.58%
EPS Q2Q%-158.96%
EPS Next Y0%
EPS Next 2Y-53.96%
EPS Next 3Y-43.38%
EPS Next 5Y-34.73%
Revenue 1Y (TTM)-60.14%
Revenue growth 3Y-20.68%
Revenue growth 5Y-8.48%
Sales Q2Q%6%
Revenue Next Year29.96%
Revenue Next 2Y-45.16%
Revenue Next 3Y-31.89%
Revenue Next 5Y-23.81%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A